Danish pharmaceutical company Novo Nordisk (NVO) topped first-quarter profit expectations, bringing in $9.5 billion in revenue over Wall Street estimates of ...
topped first-quarter profit expectations, bringing in $9.5 billion in revenue over Wall Street estimates of $9.2 billion. However, the company fell short of sales estimates for its popular GLP-1 weight-loss drug , Wegovy. Novo Nordisk also manufactures the landmark weight-loss drug Ozempic.that despite missing the mark on sales estimates , Wegovy has an"exciting growth story.
This dividend stock is near 52-week highs, but still down from all-time highs, with a highly valuable P/E ratio you won't want to miss. The post 1 Magnificent Dividend Stock That’s Down 21% and Trading at a Once-in-a-Decade Valuation appeared first on The Motley Fool Canada.Bitcoin Plunges. Here’s Why and How Far Prices Could Fall.The Canadian dollar strengthened against its U.S.
This finance YouTuber says there’s 1 retirement trap that no one talks about — here’s what you need to knowPHOENIX — Arizona is waving goodbye to a Civil War-era ban of nearly all abortions as a repeal bill reaches the desk of Democratic Gov. Katie Hobbs. Hobbs says the repeal, scheduled for signing on Thursday, is just the beginning of a fight to protect reproductive healthcare in Arizona.
The stock market's very rough April saw some of the biggest gainers of the first three months take some of the biggest dings to their market caps. And at the same time, some of the sectors that struggled in Q1 saw a similar reversal of fortune in April.Given their high yields and stable cash flows, these four dividend stocks can boost your passive income. The post Boost Your Passive Income With 4 High-Yield Stocks appeared first on The Motley Fool Canada.
Pharmaceutical Company Weight-Loss Drug Sales Estimates
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Novo Nordisk raises 2024 outlook as company races to boost output of Wegovy weight-loss drugNovo Nordisk reported better-than-expected first-quarter profits on Thursday as it looks to fend off competition from rival Eli Lilly
Read more »
Ozempic Subsidies Cut in Novo Nordisk’s Home Country of DenmarkSubsidies for Ozempic will be restricted in Novo Nordisk A/S’s home country of Denmark due to rising public spending on the blockbuster diabetes medicine, which is increasingly being used as a weight-loss treatment.
Read more »
Novo Nordisk owner to invest $200 million in quantum computing startupsExplore stories from Atlantic Canada.
Read more »
Novo Nordisk parent refiles US application on Catalent dealExplore stories from Atlantic Canada.
Read more »
Hundreds of websites are selling fake Ozempic, says company. Doctors say it's only going to get worseThis photograph taken on February 23, 2023, in Paris, shows the anti-diabetic medication 'Ozempic' (semaglutide) made by Danish pharmaceutical company 'Novo Nordisk'.
Read more »
Weight-loss drug shortage result of 'unprecedented demand'Certain doses of Eli Lilly's (LLY) GLP-1 weight loss drugs Zepbound and Mounjaro are facing a supply shortage, much like competitor Novo Nordisk's (NVO) own ...
Read more »